switching semaglutide providers to Tirzepatide: A Provider's Guide Switching between GLP‐1 receptor agonists

If youre considering treatment, start with a quick online assessment to see if its right for you.

This method helps maintain more stable medication levels, which may reduce side effects while still achieving optimal weight loss results

Suboptimal dosing : Patients may be on a dose intended for diabetes management (0.5-1.0 mg weekly) rather than the higher dose approved for weight loss (2.4 mg weekly)

Gut peptide hormones such as GLP-1 could potentially also have an impact on appetite regulation by effects on gastric emptying and direct CNS effects, but we needed a robust methodology that could be used to measure acute effect of putative hormones on subjective appetite and spontaneous food intake

Louis Aronne, the director of the Comprehensive Weight Control Center at Weill-Cornell Medical Center